CRP and Increased total leukocyte count: ‏In general, patients in the two treatment groups were similar in their baseline characteristics, except for the percentage of patients who had risk factors for drug-resistant S. pneumoniae (DRSP), the count of these factors, the percentage of patients with leukocytosis, C-reactive protein, serum level, and the duration of therapy (Table 1).